Effect of Systemic Hydrocortisone Initiated 7 to 14 Days after Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years' Corrected Age: Follow-up of a Randomized Clinical Trial: Follow-up of a Randomized Clinical Trial

Nienke M. Halbmeijer, Wes Onland, Filip Cools, Renate Swarte, Marja van der Heide-Jalving, Maruschka P. Merkus, Anton H. van Kaam

Research output: Contribution to journalComment/Letter to the editorAcademic

16 Citations (Scopus)

Abstract

This follow-up to the STOP-BPD randomized clinical trial, which investigated the efficacy and safety of systemic hydrocortisone treatment initiated 7 to 14 days after birth in ventilator-dependent, very preterm infants in the Netherlands and Belgium at 36 weeks’ postmenstrual age, examines the prespecified composite of death and neurodevelopmental impairment among these infants at 2 years’ corrected age.

Original languageEnglish
Pages (from-to)355-357
Number of pages3
JournalJAMA - Journal of the American Medical Association
Volume326
Issue number4
DOIs
Publication statusPublished - 27 Jul 2021

Keywords

  • Bronchopulmonary Dysplasia/prevention & control
  • Child, Preschool
  • Follow-Up Studies
  • Humans
  • Hydrocortisone/therapeutic use
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases/mortality
  • Neurodevelopmental Disorders/epidemiology
  • Respiration, Artificial

Cite this